Zentera Therapeutics
Shanghai, China · Founded 2018 · $75.0M raised
- Headquarters
- Shanghai
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- zenteratx.com
- Total Funding
- $75.0M
- Last Round
- Series BAug 2021
- Rounds
- 2
About
Zentera Therapeutics is a clinical-stage biopharmaceutical company developing small molecule oncology therapies, based in Shanghai.
Summary
Zentera Therapeutics is a Biotech company based in Shanghai, China, founded in 2018. It has raised $75.0M in total across 2 rounds, most recently a Series B round in Aug 2021. Investors include OrbiMed, Tybourne Capital Management and Avidity Partners.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...